September 16, 2014: Many big pharma companies are slowly shrinking when it comes to employee headcount. At the other end of the spectrum, the number of employees at big biotech firms and specialty drug makers are rapidly growing—more than offsetting the loss of jobs in big pharma.
September 16, 2014: SIGA Technologies, Inc. (SIGA) announced Tuesday that it had filed a voluntary petition for relief under chapter 11 of the U.S. Bankruptcy Code.
September 16, 2014: AstraZeneca PLC (AZN) and Eli Lilly (LLY) inked a deal to co-develop and commercialize a potential Alzheimer’s drug, the companies announced today.
September 16, 2014: Regeneron Pharmaceuticals (REGN) has announced today that the U.S. Food and Drug Administration has granted the its diabetic drug EYLEA a breakthrough therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema.